Drug Trial Radar · NCT05368285
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
Last checked: Nov 20, 2026Latest source record: Mar 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
208
Actual
Start
May 19, 2022
Primary completion
Sep 28, 2023
Study completion Dec 20, 2024
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- May 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Spontaneous Urticaria
Conditions
- Chronic Spontaneous Urticaria
Interventions
barzolvolimabBiological
Subcutaneous Administration
Matching PlaceboDrug
Subcutaneous Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change from baseline to Week 12 of UAS7 (Urticaria Activity Score)Time frame: From baseline to Day 85 (Week 12)
Locations
56 sites in 9 countries. Site status is shown where the registry gives one.
Clinical Research Center of Alabama dba Allervie Clinical Research
Birmingham, Alabama
Medical Research of Arizona
Scottsdale, Arizona
Little Rock Allergy & Asthma CRC
Little Rock, Arkansas
Kern Research, Inc
Bakersfield, California
Allergy & Asthma Consultants
Redwood City, California
IMMUNOe Research Centers
Centennial, Colorado
Treasure Valley Medical Research
Boise, Idaho
Allergy & Asthma Specialists, PSC
Owensboro, Kentucky
Institute for Asthma and Allergy
Chevy Chase, Maryland
Chesapeake Clinical Research
White Marsh, Maryland
Respiratory Medicine Research Institute of Michigan, PLC
Ypsilanti, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
Montefiore Medical Center/Subspeciality-Allergy and Immunology
The Bronx, New York
"Diagnostic Consultative Center Pulmed" EOOD
Plovdiv, Bulgaria
University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD
Plovdiv, Bulgaria
Outpatient clinic for individual practice for specialized outpatient medical care in allergology-Doctor Thalat Sally Cholak EOOD
Razgrad, Bulgaria
Medical Center Iskar EOOD Office of Clinical Allergology
Sofia, Bulgaria
Medical Center "SYNEXUS SOFIA", EOOD
Sofia, Bulgaria
Vahlberg & Pild Clinic
Tallinn, Estonia
Healthy Future
Tbilisi, Georgia
Center of Allergy and Immunology
Tbilisi, Georgia
Multiprofile Clinic Consilium Medulla
Tbilisi, Georgia
Charite - Institute of Allergology IFA Campus Benjamin Franklin
Berlin, Germany
Universitätsklinikum Heidelberg - Dermatologie
Heidelberg, Germany
LMU Klinikum - Klinik und Poliklinik für Dermatologie und Allergologie DASZ-Dermato-Allergologisches Studien Zentrum
München, Bavaria, Germany
Universitaetsklinikum Giessen u. Marburg GmbH
Marburg, Hesse, Germany
Hannover Medical University
Hanover, Lower Saxony, Germany
Klinikum Oldenburg gGmbH - Klinik f. Dermatologie u. Allergologie
Oldenburg, Lower Saxony, Germany
Universitätsklinikum Düsseldorf - Dermatologie
Düsseldorf, North Rhine-Westphalia, Germany
Universitätsklinikum Münster Klinik u. Poliklinik f. Dermatologie
Münster, North Rhine-Westphalia, Germany
Universitätsklinikum Dresden
Dresden, Saxony, Germany
Universitätsklinikum Schleswig-Holstein - Zentrum für entzündliche Hauterkrankunge
Kiel, Schleswig-Holstein, Germany
Semmelweis Egyetem, ÁOK, Bőr-, Nemikórtani és Bőronkológiai Klinika
Budapest, Hungary
Debreceni Egyetem, ÁOK és KK, Bőrgyógyászati Tanszék és Bőrgyógyászati Klinika
Debrecen, Hungary
Allergo-Derm Bakos Kft. Bőrgyógyászati Magánrendelő
Szolnok, Hungary
Óbudai Egészségügyi Centrum Kft.
Zalaegerszeg, Hungary
Centrum Medyczne Plejady
Krakow, Poland
Malopolskie Centrum Alergologii
Krakow, Poland
Uniwersytecki Szpital Kliniczny nr 1 w Lodzi
Lodz, Poland
Luxderm Specjalistyczny Gabinet Dermatologiczny Prof. Doroty Krasowskie
Lublin, Poland
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.